AiRISTA Flow, a leading global provider of location-based business solutions, announced its ongoing commitment to healthcare provider staff safety and hygiene with the debut of two modules for its new Software-as-a-Service Portal, a robust end-to-end solution for the healthcare industry that is intuitive to use, simple to deploy, and cost effective.

“Staff safety is a recurring theme in employee surveys. With the AiRISTA Flow Staff Safety Solution, nurses and staff who work alone or in isolated areas feel confident that help is a button push away,” according to a Facilities Director of a Midwest healthcare system.

Over 200 hospitals and over 500 healthcare providers trust AiRISTA Flow for all of their location needs. From inventory and equipment management to operating room efficiency and temperature monitoring, AiRISTA Flow assists healthcare providers to optimize workflows, maximize use of assets, and ensure the safety and wellbeing of patients and staff.

Highly publicized incidents have increased awareness of the need for staff safety in healthcare settings. Unions and even lawmakers are getting behind the effort. In November of 2019, the US House Representatives passed HR 1309 to protect healthcare staff, declaring, “Employers have one year to develop a provisional plan for protecting healthcare workers.”

AiRISTA Flow Staff Safety Solution utilizes Real-Time Location System (RTLS) technology and is the leading provider of two-way communicating personnel tags worldwide. The platform combines real-time insights with two-way communication tools to provide an agile solution for healthcare providers that must address or improve their staff safety programs. Deployed on-premises or via cloud portal, AiRISTA Flow Personnel Safety will remain a flexible and up-to-date solution that allows users to stay compliant with emerging legislation and the evolution of IoT technology.

The additional hand hygiene module can be added with nominal effort and expense. The module automates hand sanitization compliance in real time and provides reports at individual and group levels. The module’s flexible workflow accommodates hygiene protocols across departments and discretely alerts individuals to noncompliance.

“We are committed to the safety and wellbeing of workers across the healthcare industry. With over 10 years of experience in some of the world’s most challenging environments, safety is a deep part of our culture and we take to heart the trust our customers put in us,” said Sy Sajjad, CEO of AiRISTA Flow.

About AiRISTA Flow
AiRISTA Flow is a trusted partner in workplace safety and performance as a leading global provider of location-based business solutions that helps organizations protect their employees, optimize internal processes, and make informed decisions through cutting-edge software and industry workflow expertise. By delivering flexible solutions from end to end through a team of trusted RTLS experts that result in actionable visibility and insights, AiRISTA Flow enables faster, more accurate decision-making that improves business processes and achieves business goals

SK Telecom announced that it established a digital healthcare joint venture named Invites Healthcare with Newlake Alliance Management, a Korean private equity firm.

With the aim to facilitate the growth of healthcare business by leveraging its advanced ICT, SK Telecom created Invites Healthcare by spinning off its healthcare business unit and joining hands with partners with extensive experience in the field.

Newlake Alliance Management became the largest shareholder of Invites Healthcare. SCL Healthcare, a healthcare company in Korea, is also scheduled to participate in the joint venture.

Once SCL Healthcare’s participation is completed, Invites Healthcare will be valued at around KRW 100 billion. SK Telecom will become the second largest shareholder with a 43.4% stake. Invites Healthcare has appointed Kim Joon-yun, who served as Vice President and Head of Healthcare/IVD Unit of SK Telecom, as its Chief Executive Officer.

Invites Healthcare will carry out diverse business activities in both domestic and overseas markets aimed at improving people’s health and realizing innovations for medical institutions through the use of cutting-edge ICT.

Invites Healthcare will develop ICT-based chronic disease management services to help people with chronic illnesses – e.g. cardiovascular diseases, respiratory illnesses, brain diseases, etc. – better manage their conditions. In this context, it will also take over and operate ‘Coach-coach Diabetes’, a digital diabetes management platform/app developed by SK Telecom.

Coach-coach Diabetes enables diabetic patients to self-manage their blood sugar level, diet and exercises, and allows physicians to monitor patient data in real time.

Moreover, Invites Healthcare plans to promote smart solutions business to realize ICT-driven innovations at medical institutions including hospitals. For instance, it will launch Smart MRO (Maintenance, Repair and Operation) business to boost hospitals’ operational efficiency by helping with their purchasing and management of medical supplies. It will also develop ground-breaking cloud-based solutions powered by SK Telecom’s quantum cryptography and blockchain technologies to enable medical institutions to securely store and efficiently analyze vast amount of medical data.

Furthermore, Invites Healthcare plans to seek opportunities in the overseas healthcare markets through partnerships and collaborations. It will start by taking over SK Telecom’s global healthcare partnerships in the Middle East and Asia.

“As a digital healthcare company, Invites Healthcare will promote diverse business opportunities by applying state-of-the-art ICT to medical fields,” said Kim Joon-yun, CEO of Invites Healthcare. “Ultimately, Invites Healthcare will offer a wide variety of digital healthcare services that can help people protect their health and lead innovations in the digital healthcare ecosystem.”

HEI Health is releasing their proprietary in-house software application, CollabApp, free to hospitals and healthcare facilities to help them be more productive if hourly revenue cycle workers are sent home for the next few months or longer. With the current crisis, it is easy for hourly workers to feel alone or get distracted, to be afraid for coworkers, or worry if they will have a job to return to.

CollabApp software helps hospitals manage their entire hourly revenue cycle workforce remotely, keeping them profitable and productive, while mimicking the office environment. Workers can see each other, chat, and feel less alone while working. They can also help each other with their work if there are questions.

Most online team collaboration software is not designed for continuous online collaboration. Meetings must be scheduled and “time out.” And the number of “seats” are either limited or can become expensive depending on the application.

What is CollabApp?

CollabApp is a team collaboration working environment that allows managers and employees to see one another and work remotely while being able to ask questions, seek help, share documents and stay connected to their workplace and coworkers continuously. This helps create a “normalcy” that existed when they were working together in the office. And makes managing employees easier.

CollabApp is easy to deploy, and easy to use by anyone familiar with popular, online social media apps.

CollabApp can easily be added to a hospital emergency business continuity plan in a hurry.

It is also quick and easy for managers and employees to learn and begin using immediately.It is also tiered so that, for a fee, it can seamlessly be used as part of a larger suite of performance-enhancing and scoring tools.

RSIP Vision, a global leader in artificial intelligence (AI) and computer vision technology, announced a new innovative AI-based solution for 3D reconstruction of knees from X-ray images. This technology provides physicians with a rich 3D modelling of each bone, which could provide critical data for surgery planning and implants fitting, improving physicians’ workflow and reducing the need for high-cost and high-radiation currently used methods. Physicians will receive a precise 3D anatomical model of the patient knee, enabling optimal pre-op planning and precise implant tailoring.

X-ray scanners are widely available and cheaper than CT or MRI scanners. Moreover, they expose the patients to much less radiation compared to CT scanners. However, X-ray images give only 2D information resulting from the summation of the 3D rays through the anatomical objects. As a result, doctors usually take two X-rays images of lateral and AP views for a rough estimate of the 3D anatomical structure. Nevertheless, what is still missing is a rich 3D modelling of each bone, which could provide critical data for surgery planning and implants fitting. The new technology developed by RSIP Vision generates a 3D model of the knee joint from two X-ray images of AP and lateral views.

The model is based on convolutional neural networks, a recent technique which have been proven to be very effective for various types of tasks. In particular, deep neural networks-based models outperform all previous approaches for image segmentation. However, 3D reconstruction from 2D images is still challenging for neural networks, due to the difficulty of representing a dimensional enlargement with standard differentiable layers. Reconstruction of bone surfaces in particular is extremely challenging, due to the transparent nature of the X-ray images. RSIP Vision addresses these challenges by introducing a special dimensional enlargement layer.

The main usage of the 3D model is for planning and accurate measurements that are needed to precise fit of the implant or for patient specific intraoperative guidance.

Accordingly, the testing has been done by comparing the 3D model to a CT scan of the patient. The distance between the model and the real scan is the precision measure we need. From our testing – the accuracy of this technology is close to 1mm, which is the required precision needed for best fit for the implant in total knee replacement.

The results show that this new technology is very effective for reconstructing 3D models of knee bones from two standard bi-planar X-ray views. The deep neural network model, together with synthetic data creation and effective training process, proves to be a powerful technique to create a rich 3D modelling of each bone with low-cost, widely available and low-radiation imaging modality.

“Knee replacement surgeries are common, among other joint surgeries. The most important factor for achieving high accuracy and success rates is preoperative planning, during which the orthopedic surgeon normally uses an expensive, time consuming, scarcely available modalities (CT, MRI…). To overcome this obstacle, RSIP Vision developed a new technology based solely on X-ray beams that is readily available, accurate, cheap and reproducible, which could be applied in poor peripheral as in rich central areas, while preserving the segmentation quality.” says Dr. Rabeeh Fares, Radiologist; Department of Diagnostic Radiology, Sourasky Medical Center, Tel Aviv.

RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy (BgRT) to treat all stages of cancer announced it has received marketing clearance from the U.S. Food & Drug Administration (FDA) for stereotactic body radiotherapy (SBRT), stereotactic radiosurgery (SRS) and intensity modulated radiotherapy (IMRT) for its RefleXion™ X1 machine.

“We are at the forefront of an enormous change in expanding the use of radiotherapy from a treatment solely for early-stage cancer patients to an entirely new group of patients who need it most, those with advanced stage cancer,” said Todd Powell, CEO and president of RefleXion. “This initial marketing clearance of our RefleXion X1 machine is a steppingstone on the path to our goal of providing BgRT as a novel treatment modality that will expand the overall radiotherapy market significantly.

“We have been preparing for commercial operations in the brand new factory we opened last year and expect to begin machine shipments within the next quarter,” continued Powell.

The RefleXion X1 is the only machine that combines high quality computed tomography (CT) imaging, known as fan-beam CT, with a linear accelerator to reduce motion artifacts that can inhibit accurate targeting of the radiation dose to a patient’s tumor. Its groundbreaking design rotates up to 60 times faster than other linear accelerators and modulates dose delivery from 100 points per beam station. These combined improvements may reduce the side effects of radiotherapy by allowing radiation oncologists to better localize the tumor, reduce patient setup errors and precisely deliver dose to complex tumor targets while avoiding nearby normal structures.

“Transitioning this company from a research effort to what is, as of today, a commercial entity has been a thrilling 10-year journey,” said Sam Mazin, Ph.D., founder and CTO of RefleXion. “Along the way, RefleXion has become an organization supported by dedicated and brilliant people in every corner, including our clinical partners. We will celebrate this milestone and then quickly turn our sights to bringing our biology-guided radiotherapy to market.”

BgRT, a novel treatment modality under development, uses the biological signature of a tumor to characterize its movement and to deliver a precisely tracked therapeutic radiation dose to the tumor. The RefleXion X1 machine with BgRT is designed to overcome the technical limitations that currently restrict radiotherapy to one or two tumors. Once developed, RefleXion will scale BgRT to treat all visible tumors, even those that move rapidly due to involuntary processes such as breathing or digestion, in the same treatment session.
About RefleXion Medical

RefleXion is a privately-held company developing the first biology-guided radiotherapy system, a significant change in strategy from single tumor therapy to the ability to one day treat multiple tumors in the same treatment session in cancers that have metastasized. Currently, the RefleXion machine is cleared for the delivery of stereotactic body radiotherapy (SBRT), stereotactic radiosurgery (SRS) and intensity modulated radiotherapy (IMRT). The company is also developing BgRT, which incorporates positron-emission tomography (PET) imaging data to enable tumors to continuously signal their location. The BgRT technology will synchronize these data with the linear accelerator to direct radiotherapy to tumors with subsecond latency.

RefleXion is backed by premier investment firms TPG Growth/The Rise Fund, Sofinnova Partners, KCK Group, Venrock, T. Rowe Price and global pharmaceutical leaders Pfizer Venture Investments and Johnson & Johnson Innovation, JJDC Inc.